Latest Breaking News On - Canadian urologic association bladder cancer forum - Page 1 : comparemela.com

Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) is eyeing regulatory approval for its lead asset, the bladder cancer treatment Rudivar, by 2026,.

United statesSan antonioKristina hacheyHealth canadaCanadian urologic association bladder cancer forumTheralase technologies incDrug divisionAmerican urology associationUrology association